Filter
1777
Filtered Results: 1777
Text search:
National
Medicines
Regulatory
Authority
Featured
Recommendations
168
New Publications
478
Language
Document type
No document type
813
Studies & Reports
345
Guidelines
315
Manuals
131
Strategic & Response Plan
110
Fact sheets
26
Situation Updates
15
Training Material
12
Resource Platforms
4
Brochures
3
Infographics
2
Online Courses
1
Countries / Regions
Global
77
Kenya
65
India
60
Ethiopia
49
Uganda
37
Nigeria
36
South Africa
35
Liberia
34
Western and Central Europe
33
Ghana
30
Tanzania
30
Zambia
29
Africa
27
Sierra Leone
26
Latin America and the Carribbean
25
Ukraine
24
Nepal
23
Bangladesh
22
South–East Asia Region
21
Rwanda
20
Malawi
18
Namibia
18
Eastern Europe
17
Myanmar / Burma
15
Syria
13
West and Central Africa
13
Lesotho
12
Zimbabwe
12
Philippines
12
East and Southern Africa
11
Guinea
9
Eswatini/ Swaziland
9
Asia
8
Middle East and North Africa
8
Cambodia
7
Botswana
7
Congo, Democratic Republic of
6
Indonesia
6
Mozambique
5
USA
5
Eastern Europe and Central Asia
5
Sudan
5
Pakistan
5
Senegal
4
Jordan
4
Western Pacific Region
4
North America
4
Moldova
4
Georgia
4
Somalia
4
Tajikistan
3
Thailand
3
Benin
3
Cameroon
3
Albania
3
Laos
3
Burkina Faso
3
Afghanistan
3
Haiti
3
Germany
3
Iran
2
Peru
2
Turkmenistan
2
Bosnia and Herzegovina
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Russia
2
South Sudan
2
Ecuador
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
Turkey
1
Australia
1
Kazakhstan
1
Chile
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Morocco
1
Qatar
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Belarus
1
Bolivia
1
Brazil
1
Sri Lanka
1
Egypt
1
Greece
1
Palestine
1
Mali
1
Chad
1
Libya
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
662
Clinical Guidelines
145
Public Health
115
Women & Child Health
69
Key Resources
68
Pharmacy & Technologies
52
Capacity Building
13
Toolboxes
AMR
146
HIV
127
COVID-19
120
Pharmacy
120
TB
108
Mental Health
71
Planetary Health
62
Caregiver
54
Rapid Response
40
NTDs
37
Malaria
37
Global Health Education
37
Ebola & Marburg
36
NCDs
32
Conflict
28
2.0 Rapid Response
22
Disability
20
Specific Hazards
19
Health Financing Toolbox
18
Refugee
16
Natural Hazards
15
Zika
10
Polio
8
Cholera
5
Social Ethics
2
On the road to ending TB
Highlights from the 30 highest TB burden countries
One important application of digital health in TB patient care is the support that it can lend to medication adherence. TB programmes have already been using short message service (SMS), video-supported treatment (VOT) and event monitoring device for medication support ...
Module 8
Site Planning
July 2017
Module 8: Site planning. This module is for people involved in organizing PrEP services at specific sites. It outlines the steps to be taken in planning a PrEP service and gives suggestions for personnel, infrastructure and commodities that could be considered...
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
Despite the existence of criminal law, which is an important aspect of anti-FGM policies and programmes, there is not much research on the effects of cross-border practices that invalidate the law as a deterrent. Much remains unknown about the practice of cross-border FGM, specifically about gaps in...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Noncommunicable diseases (NCDs) (e.g., cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases) and mental health conditions (e.g., Alzheimer’s disease and related dementias, depression, anxiety, autism spectrum disorders) are the world’s leading cause of preventable illness...
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands...
This report presents an assessment of the institutional readiness to detect, prevent and address health issues associated with ASGM and aims to provide an input to the Ministry of Health (MISAU) to define key priorities in the Public Health Strategy on ASGM. Based on the consultation of representati...
This guide provides an overview of the major elements that must be considered before, during and after the implementation of antigen-detecting rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2. This guide is complementary to policy guidance issued by the World Health Organization (WHO). The guide may ...
The rapid arrival of millions of asylum seekers and migrants in Europe in 2015–16 forced cities both large and small to rethink their approach to immigrant inclusion.
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become resistant to antimicrobial agents they can pose a greater human health risk as a result of potential treatment failure, loss of treatment options and increased likelihood and severi...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
